a Smptomatic Bacteriuria in Pregnancy

January 8, 2019 updated by: Mahmoud Alalfy, Aljazeera Hospital

a Symptomatic Bacteriuria in Pregnant Females

Asymptomatic bacteriuria (ASB) is defined as the presence of at least 105 colony-forming units (CFU)/ml of 1 or 2 bacterial species in clean-voided midstream urine sample from an individual without symptoms of UTI

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

ASB is common in women and increases in prevalence with age and/or sexual activity, due to short urethra, pregnancy, easy contamination of urinary tract with fecal flora

The pregnant women are two times more commonly affected than age matched non pregnant females. This is due to urinary stasis due to progesterone effect in pregnancy in addition to different morphological and physiological changes occurring during pregnancy The prevalence of ASB is about 3 times higher in diabetic women (ranging from 15% to 30%) than in non-diabetic women (less than 10%)

Study Type

Observational

Enrollment (Anticipated)

320

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Giza, Egypt
        • Recruiting
        • Algazeerah

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years to 40 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Pregnant non-symptomatic females.

Description

Inclusion Criteria:

  • 1. Pregnant females 2. Non-symptomatic females.

Exclusion Criteria:

  • 1. Patients taking antibiotics in the last two weeks. 2. Symptomatic UTI. 3. Suspected urinary tract abnormalities. 4. Urinary catheterization. 5. Renal dialysis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
pregnant women in first Trimester
A urine sample will be taken from pregnant women before 14 weeks of pregnancy
Intervention is (urine analysis ): of a mid stream urine sample will be taken
pregnant women in second Trimester
A urine sample will be taken from pregnant women from 14 weeks +1 day till 28 weeks
Intervention is (urine analysis ): of a mid stream urine sample will be taken
pregnant women in third Trimester
A urine sample will be taken from pregnant women from 28 weeks +1 day till 40 weeks
Intervention is (urine analysis ): of a mid stream urine sample will be taken

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of participants who will discovered to have bacteriuria
Time Frame: within 4 weeks
Incidence of asymptomatic bacteriuria among pregnant females.
within 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 17, 2018

Primary Completion (Anticipated)

May 1, 2019

Study Completion (Anticipated)

July 15, 2019

Study Registration Dates

First Submitted

April 6, 2018

First Submitted That Met QC Criteria

April 9, 2018

First Posted (Actual)

April 17, 2018

Study Record Updates

Last Update Posted (Actual)

January 9, 2019

Last Update Submitted That Met QC Criteria

January 8, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • A symptomatic bacteriuria

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The research will be published after finishing results

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bacteriuria in Pregnancy

Clinical Trials on urine analysis

3
Subscribe